Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India

M. Radhakrishna Pillai, S. Sreevidya, Bradley H Pollock, P. G. Jayaprakash, Brian Herman

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Purpose: It has been suggested that host genetic factors play a role in human papillomavirus (HPV)-associated tumorigenesis, although the issue continues to be a focus of much debate. Previous studies have reported that a common polymorphism of the wild type p53 gene at codon 72 of exon 4 (Arg/Arg) is associated with a sevenfold increased risk of HPV-associated cancer compared to Arg/Pro and Pro/Pro polymorphisms. In vitro studies also suggested that the Arg/Arg polymorphism was much more susceptible to HPV 16 E6-mediated degradation as compared to other allelic forms. Subsequent studies published since this initial report indicated geographical differences with respect to the role of Arg/Arg polymorphism in increasing the risk of HPV-associated cervical cancer. Methods: In this study we analyzed leukocyte DNA from a total of 421 subjects for the Arg/Arg, Arg/Pro or Pro/Pro p53 polymorphisms at various stages of the cervical tumor progression spectrum, using allele-specific PCR. All subjects were from the Thiruvananthapuram District of South India. HPV genotyping was done for all subjects using either DNA extracted from cervical biopsies or exfoliated cervical cells. All subjects were grouped on the basis of both of cyto-pathology and HPV status. Results: The distribution of p53 genotypes was not significantly different in all study groups (HPV positive vs HPV negative and cases vs controls comparisons). Homozygosity for Arg/Arg was not associated with increased risk for cervical cancer. Conclusion: We find no evidence for any association between homozygosity for p53 arginine with either cervical dysplasia, cervical carcinoma or HPV infection in the population from South India.

Original languageEnglish (US)
Pages (from-to)627-631
Number of pages5
JournalJournal of Cancer Research and Clinical Oncology
Volume128
Issue number11
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Codon
Uterine Cervical Neoplasms
India
Uterine Cervical Dysplasia
Papillomavirus Infections
Human papillomavirus 16
DNA
p53 Genes
Arginine
Exons
Neoplasms
Carcinogenesis
Leukocytes
Alleles
Genotype
Pathology
Carcinoma
Biopsy
Polymerase Chain Reaction
Population

Keywords

  • Cervical carcinoma
  • HPV
  • p53
  • Polymorphism

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India. / Pillai, M. Radhakrishna; Sreevidya, S.; Pollock, Bradley H; Jayaprakash, P. G.; Herman, Brian.

In: Journal of Cancer Research and Clinical Oncology, Vol. 128, No. 11, 2002, p. 627-631.

Research output: Contribution to journalArticle

Pillai, M. Radhakrishna ; Sreevidya, S. ; Pollock, Bradley H ; Jayaprakash, P. G. ; Herman, Brian. / Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India. In: Journal of Cancer Research and Clinical Oncology. 2002 ; Vol. 128, No. 11. pp. 627-631.
@article{b0b008eaec9244089002ebcead843d49,
title = "Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India",
abstract = "Purpose: It has been suggested that host genetic factors play a role in human papillomavirus (HPV)-associated tumorigenesis, although the issue continues to be a focus of much debate. Previous studies have reported that a common polymorphism of the wild type p53 gene at codon 72 of exon 4 (Arg/Arg) is associated with a sevenfold increased risk of HPV-associated cancer compared to Arg/Pro and Pro/Pro polymorphisms. In vitro studies also suggested that the Arg/Arg polymorphism was much more susceptible to HPV 16 E6-mediated degradation as compared to other allelic forms. Subsequent studies published since this initial report indicated geographical differences with respect to the role of Arg/Arg polymorphism in increasing the risk of HPV-associated cervical cancer. Methods: In this study we analyzed leukocyte DNA from a total of 421 subjects for the Arg/Arg, Arg/Pro or Pro/Pro p53 polymorphisms at various stages of the cervical tumor progression spectrum, using allele-specific PCR. All subjects were from the Thiruvananthapuram District of South India. HPV genotyping was done for all subjects using either DNA extracted from cervical biopsies or exfoliated cervical cells. All subjects were grouped on the basis of both of cyto-pathology and HPV status. Results: The distribution of p53 genotypes was not significantly different in all study groups (HPV positive vs HPV negative and cases vs controls comparisons). Homozygosity for Arg/Arg was not associated with increased risk for cervical cancer. Conclusion: We find no evidence for any association between homozygosity for p53 arginine with either cervical dysplasia, cervical carcinoma or HPV infection in the population from South India.",
keywords = "Cervical carcinoma, HPV, p53, Polymorphism",
author = "Pillai, {M. Radhakrishna} and S. Sreevidya and Pollock, {Bradley H} and Jayaprakash, {P. G.} and Brian Herman",
year = "2002",
doi = "10.1007/s00432-002-0383-9",
language = "English (US)",
volume = "128",
pages = "627--631",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "11",

}

TY - JOUR

T1 - Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India

AU - Pillai, M. Radhakrishna

AU - Sreevidya, S.

AU - Pollock, Bradley H

AU - Jayaprakash, P. G.

AU - Herman, Brian

PY - 2002

Y1 - 2002

N2 - Purpose: It has been suggested that host genetic factors play a role in human papillomavirus (HPV)-associated tumorigenesis, although the issue continues to be a focus of much debate. Previous studies have reported that a common polymorphism of the wild type p53 gene at codon 72 of exon 4 (Arg/Arg) is associated with a sevenfold increased risk of HPV-associated cancer compared to Arg/Pro and Pro/Pro polymorphisms. In vitro studies also suggested that the Arg/Arg polymorphism was much more susceptible to HPV 16 E6-mediated degradation as compared to other allelic forms. Subsequent studies published since this initial report indicated geographical differences with respect to the role of Arg/Arg polymorphism in increasing the risk of HPV-associated cervical cancer. Methods: In this study we analyzed leukocyte DNA from a total of 421 subjects for the Arg/Arg, Arg/Pro or Pro/Pro p53 polymorphisms at various stages of the cervical tumor progression spectrum, using allele-specific PCR. All subjects were from the Thiruvananthapuram District of South India. HPV genotyping was done for all subjects using either DNA extracted from cervical biopsies or exfoliated cervical cells. All subjects were grouped on the basis of both of cyto-pathology and HPV status. Results: The distribution of p53 genotypes was not significantly different in all study groups (HPV positive vs HPV negative and cases vs controls comparisons). Homozygosity for Arg/Arg was not associated with increased risk for cervical cancer. Conclusion: We find no evidence for any association between homozygosity for p53 arginine with either cervical dysplasia, cervical carcinoma or HPV infection in the population from South India.

AB - Purpose: It has been suggested that host genetic factors play a role in human papillomavirus (HPV)-associated tumorigenesis, although the issue continues to be a focus of much debate. Previous studies have reported that a common polymorphism of the wild type p53 gene at codon 72 of exon 4 (Arg/Arg) is associated with a sevenfold increased risk of HPV-associated cancer compared to Arg/Pro and Pro/Pro polymorphisms. In vitro studies also suggested that the Arg/Arg polymorphism was much more susceptible to HPV 16 E6-mediated degradation as compared to other allelic forms. Subsequent studies published since this initial report indicated geographical differences with respect to the role of Arg/Arg polymorphism in increasing the risk of HPV-associated cervical cancer. Methods: In this study we analyzed leukocyte DNA from a total of 421 subjects for the Arg/Arg, Arg/Pro or Pro/Pro p53 polymorphisms at various stages of the cervical tumor progression spectrum, using allele-specific PCR. All subjects were from the Thiruvananthapuram District of South India. HPV genotyping was done for all subjects using either DNA extracted from cervical biopsies or exfoliated cervical cells. All subjects were grouped on the basis of both of cyto-pathology and HPV status. Results: The distribution of p53 genotypes was not significantly different in all study groups (HPV positive vs HPV negative and cases vs controls comparisons). Homozygosity for Arg/Arg was not associated with increased risk for cervical cancer. Conclusion: We find no evidence for any association between homozygosity for p53 arginine with either cervical dysplasia, cervical carcinoma or HPV infection in the population from South India.

KW - Cervical carcinoma

KW - HPV

KW - p53

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=0036451239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036451239&partnerID=8YFLogxK

U2 - 10.1007/s00432-002-0383-9

DO - 10.1007/s00432-002-0383-9

M3 - Article

C2 - 12458344

AN - SCOPUS:0036451239

VL - 128

SP - 627

EP - 631

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 11

ER -